Sciencebiotech
A small RNA switch opens new doors for synthetic biology
An international research team led by TU Darmstadt Professor Beatrix Süß has elucidated how a newly developed RNA switch recognizes the antibiotic doxycycline. This mechanism selectively activates or deactivates gene expression. The findings, published in Nature Communications, establish doxycycline as a promising chemical tool for synthetic biology. Researchers hope this innovation will pave the way for advanced gene therapies in the future.